Monoclonal infection involving Mycobacterium avium presenting with three distinct colony morphotypes

Journal of Clinical Microbiology

Volumn 34, Issue 10, 1996, Pages 2475-2478

  Wright, Esther L ^a   Zywno van Ginkel, Sabrina ^a   Rastogi, Nalin ^b   Barrow, William W ^a,c  

^a SOUTHERN RESEARCH INSTITUTE   (United States)

^b Institut Pasteur of Guadeloupe   (Guadeloupe)

^c Mycobacteriology Research Unit   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; GLYCOPEPTIDE; LIPID; MYCOLIC ACID;

ARTICLE; BACTERIUM COLONY; BACTERIUM EXAMINATION; CASE REPORT; HUMAN; LIPID ANALYSIS; MALE; MORPHOLOGY; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM AVIUM;

EID: 0029815691     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.34.10.2475-2478.1996     Document Type: Article

References (20)

1. Arbeit, R. D., A. Slutsky, T. W. Barber, J. N. Maslow, S. Niemczyk, J. O. F. III, G. T. O'Connor, and C. F. vonReyn. 1993. Genetic diversity among strains of Mycobacterium avium causing monoclonal and polyclonal bacteremia in patients with AIDS. J. Infect. Dis. 167:1384-1390.
2. Barnes, P. F., H. Q. Le, and P. T. Davidson. 1993. Tuberculosis in patients with HIV infection. Med. Clin. North Am. 77:1369-1390.
3. Barrow, W. W., and P. J. Brennan. 1982. Isolation in high frequency of rough variants of Mycobacterium intracellulare lacking C-mycoside glycopeptidolipid antigens. J. Bacteriol. 150:381-384.
4. Barrow, W. W., T. L. Davis, E. L. Wright, V. Labrousse, M. Bachelet, and N. Rastogi. 1995. Immunomodulatory spectrum of lipids associated with Mycobacterium avium serovar 8. Infect. Immun. 63:126-133.
5. Barrow, W. W., E. L. Wright, K. S. Goh, and N. Rastogi. 1993. Activities of fluoroquinolone, macrolide, and aminoglycoside drugs combined with inhibitors of glycosylation and fatty acid and peptide biosynthesis against Mycobacterium avium. Antimicrob. Agents Chemother. 37:652-661.
6. David, H. L. 1981. Basis for lack of drug susceptibility of atypical mycobacteria. Rev. Infect. Dis. 3:878-884.
7. Ellner, J. J., M. J. Goldberger, and D. M. Parenti. 1991. Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution. J. Infect. Dis. 163:1326-1335.
8. Fregnan, G. B., and D. W. Smith. 1962. Description of various colony forms of mycobacteria. J. Bacteriol. 83:819-827.
9. Goren, M., and P. J. Brennan. 1979, Mycobacterial lipids: chemistry and biological activities, p. 63-193. In G. P. Youmans (ed.), Tuberculosis. W. B. Saunders Co., Philadelphia.
10. Guerrero, C., C. Bernasconi, D. Burki, T. Bodmer, and A. Telenti. 1995. A novel insertion element from Mycobacterium avium, IS1245, is a specific target for analysis of strain relatedness. J. Clin. Microbiol. 33:304-307.
11. Heifets, L. B. 1991. Dilemmas and realities in drug susceptibility testing of M. avium and M. intracellulare and other slowly growing nontuberculosis mycobacteria, p. 123-141. In L. B. Heifets (ed.). Drug susceptibility in the chemotherapy of mycobacterial infections. CRC Press, Boca Raton, Fla.
12. Kubica, G. P., and D. W. Smith. 1965. Differential colonial characteristics of mycobacteria on oleic acid-albumin and modified corn meal agars. I. Investigation of slowly growing mycobacteria. Zentralbl. Bakteriol. 196:53-59.
13. Rastogi, N. 1991. Structure and functions of the cell envelope in relation to mycobacterial virulence, pathogenicity and multiple drug resistance, 7th forum in microbiology. Res. Microbiol. 142:419-481.
14. Rastogi, N., K. S. Goh, S. Z. V. Ginkel, E. L. Wright, and W. W. Barrow. 1996. Identification of new drug targets in Mycobacterium avium and Mycobacterium tuberculosis. Res. Microbiol. 147:97-105.
15. Rastogi, N., K. S. Goh, E. L. Wright, and W. W. Barrow. 1994. Potential drug targets for Mycobacterium avium defined by using radiometric drug-inhibitor combination techniques. Antimicrob. Agents Chemother. 38:2287-2295.
16. Slutsky, A. M., R. D. Arbeit, T. W. Barber, J. Rich, C. F. vonReyn, W. Pieciak, M. A. Barlow, and J. N. Maslow. 1994. Polydonal infections due to Mycabacterium avium complex in patients with AIDS detected by pulsed-field gel electrophoresis of sequential clinical isolates. J. Clin. Microbiol. 32:1773-1778.
17. Tsang, A. Y., I. Urupa, M. Goldberg, J. K. McClatchy, and P. J. Brennan. 1983. Use of serology and thin-layer diromatography for the assembly of an authenticated collection of serovars within the Mycobacterium avium-Mycobacterium intracellulare-Mycobacterium scrofulaccum complex. Int. J. Syst. Bacteriol. 33:285-292.
18. von Reyn, C. F., N. J. Jacobs, R. D. Arbeit, J. N. Maslow, and S. Niemczyk. 1995. Polyclonal Mycobacterium avium infections in patients with AIDS: variations in antimicrobial susceptibilities of different strains of M. avium isolated from the same patient. J. Clin. Microbiol. 33:1008-1010.
19. von Reyn, C. F., M. Pestel, and R. D. Arbeit. 1996. Clinical and epidemiologic implications of polyclonal infection due to Mycobacterium avium complex. Res. Microbiol. 147:24-30.
20. Wright, E. L., and W. W. Barrow. 1991. Inhibition of glycopeptidolipid synthesis resulting from treatment of Mycobacterium avium with 2-deoxy-D-glucose. Res. Microbiol. 142:597-608.